
An analysis found that out of 1,357 AI-enabled medical devices cleared by the FDA, only three were actually tested for their effect on patient health outcomes.
Key Details
- 11,357 FDA-cleared AI medical devices were analyzed.
- 2Only 34 devices had associated registered clinical trials.
- 3Just 3 devices were tested for patient-centered outcomes like survival or quality of life.
- 4Most studies excluded groups like pregnant women, older adults, and non-English speakers.
- 5Current FDA clearance requires 'substantial equivalence,' not proven patient benefit.
- 6Authors propose new frameworks for requiring outcome-based evidence across diverse populations.
Why It Matters

Source
EurekAlert
Related News

Advances in 3D-Printed Devices for Structured-Light Imaging
Researchers review femtosecond laser 3D microfabrication for integrated structured-light optical devices.

Deep Learning and MRI Identify Cognitive Impairment in CKD Patients
Researchers used multimodal MRI and a novel deep learning model to identify cognitive impairment in chronic kidney disease patients with strong validation.

Deep Learning Tool Predicts DBS Outcomes in Dystonia via MRI
Researchers developed a deep learning algorithm (DystoniaDBSNet) that uses MRI scans to predict which dystonia patients will benefit from deep brain stimulation (DBS) surgery.